Research goes through centralized publishing houses that are slow and biased. Once it is published is expensive to access, limiting science to elites. I have more written about this issue and what I see as the solution that I will share in the future.
I’d love to learn more about your startup and work! I’ve done some work in the biomedical field but I don’t know anything about cell reprogramming. Based off the quick search I did it seems cool!
Login to reply
Replies (1)
making stem cells from differentiated cells!
the state of the art to most is high throughput screening. Our approach is to identify signals cells use to coordinate towards the shared goal of ‘be cell type x now’ so that we might achieve a more effective outcome.
typically reprogramming is <1% effective.
Improving this yield is a key bottleneck to translating this technology for regenerative medicine applications and aging